Multielectrode Microsensor Coatings for Clozapine Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing electrochemical detection methods struggle to accurately detect redox-active drugs like clozapine in small biofluid samples, particularly in finger-prick blood volumes, due to interference from other molecules and the need for improved sensitivity and specificity.
Innovation Solution
An electrochemical microsensor with a multielectrode array coated with thin films of transition metal chalcogenides and other materials, combined with chemometric analysis, is used to enhance sensitivity and enable detection of clozapine in small blood samples.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional electrochemical detection methods are used, then the detection process is simple, but the sensitivity and ability to detect drugs in small biofluid samples is insufficient
Solution Approach 1:
The sensor is divided into multiple working electrodes (at least three) with different surface modifications within a single device. Each electrode is segmented to have specific coating materials (chitosan, carbon nanotubes, reduced graphene oxide) that target different aspects of drug detection, allowing the system to achieve high sensitivity through combined signals from multiple specialized electrodes
Solution Approach 2:
The working electrodes are coated with composite materials combining different properties: chitosan provides selectivity, carbon nanotubes enhance electron transfer, and reduced graphene oxide improves surface area and catalytic activity. These composite coatings on multiple electrodes work together to achieve superior detection sensitivity while managing device complexity
2Measurement precision
If standard electrode coatings are used, then the manufacturing process is straightforward, but the limit of detection remains high and insufficient for trace drug analysis
Solution Approach 1:
The patent optimizes specific parameters of the electrode coatings including thickness (controlling electron transfer rates), composition ratios of different materials, and surface area of each electrode. By carefully adjusting these parameters during fabrication, the system achieves low detection limits while maintaining a relatively streamlined manufacturing process using established coating techniques
Solution Approach 2:
Different regions of the sensor array have electrodes with locally optimized coatings tailored to specific detection needs. Each electrode receives a customized coating composition and thickness appropriate for its intended function, allowing the overall system to achieve superior detection capability without requiring complete redesign of the entire manufacturing process
3Measurement precision
If single electrode sensors are used, then the device is simple to operate, but interferants in biofluid samples mask the analyte signal and reduce detectability
Solution Approach 1:
The sensor uses multiple working electrodes (at least three) with different surface modifications to segment the detection function. Each electrode responds differently to the target drug versus interferants present in biofluid samples. By comparing and analyzing the differential responses from multiple electrodes, the system can distinguish the analyte signal from masking interferants, significantly improving signal detectability
Solution Approach 2:
The system employs chemometric analysis and pattern recognition algorithms that process signals from multiple electrodes simultaneously. This analytical feedback mechanism identifies characteristic signal patterns of the target drug across the electrode array, distinguishing them from interferant signals and enabling accurate detection even when interferants are present in the sample
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The microsensor achieves a low limit of detection (LoD) of approximately 0.08±9.2×10−4 μM for capillary plasma and 0.45±0.04 μM for capillary whole blood samples, matching the accuracy of liquid chromatography-mass spectrometry.
Implementation Method 1
Some drugs lend themselves to electrochemical detection e.g., in blood or urine samples, owing to their ability to undergo oxidation-reduction reaction to generate concentration-dependent electrochemical signal
Implementation Method 2
incorporation into the multielectrode array of WO 2018/225058 two or more additional electrodes coated with especially thin films (few nanometers thick), e.g., thin films consisting of electrocatalytically active transition metal chalcogenides
Data Source
AI summary
An electrochemical microsensor comprising an array of working microelectrodes, the working microelectrodes include:one or more bare microelectrodes;one or more thick film-coated microelectrodes, optionally with conductive additive incorporated into the coating, selected from the group consisting of polysaccharide-coated microelectrodes and platinum black-coated microelectrodes;one or more thin film-coated microelectrodes selected from the group consisting of reduced graphene oxide-coated microelectrode and transition metal chalcogenide-coated microelectrodes;wherein the electrochemical microsensor further comprises a counter electrode and optionally one or more reference microelectrode(s).


